![]()
THE PHYSICIAN AND SPORTSMEDICINE - VOL 26 - NO. 9 - SEPTEMBER 98
Study Critiques Cardiac Screening of Athletes: Time for a National Standard?The preparticipation examination forms used in most states have deficiencies that seriously reduce the chance of detecting potentially lethal cardiovascular conditions in high school athletes, according to a report in a recent issue of The Journal of the American Medical Association (1). The authors say they hope the report will spur efforts to establish national standards for the history and physical exam forms. The researchers examined the preparticipation physical exam (PPE) standards used in all 50 states and the District of Columbia and compared them with the American Heart Association's (AHA) 1996 guidelines on screening for cardiac abnormalities (2). Their main findings:
None of the states had history forms that addressed all 13 questions recommended by the AHA, says David W. Glover, MD, coauthor of the JAMA report and a family physician practicing in Warrensburg, Missouri. A national mandate is needed, Glover says, because "we have 51 different organizations, and it's very unlikely that they're all going to do well revising their PPE forms." Critical IssuesCardiac screening poses difficult problems because potentially fatal abnormalities are rare and in some cases undetectable without echocardiography or other sophisticated tests. Nevertheless, Glover and Maron say in their report that preparticipation screening by history and physical exam can uncover or raise the suspicion of such disease in some athletes, such as those who have hypertrophic cardiomyopathy (HCM) or Marfan syndrome. Until recently, there have been no data showing the efficacy of cardiac screening exams. An Italian study, published in the August 6 issue of The New England Journal of Medicine (3), presents indirect evidence that screening reduces sudden death from HCM. The prospective study compared the sudden death rates of athletes and nonathletes (age 35 or younger) in the Veneto region of Italy from 1979 to 1996. (Since 1971, Italian law has required that competitive athletes undergo screening. The cardiovascular component includes history, family history, physical exam, 12-lead electrocardiography, and limited exercise testing.) HCM caused 2.0% (1 death) of sudden deaths among athletes, and 7.3% (16 deaths) among nonathletes. Barry J. Maron, MD, coauthor of the JAMA report and director of cardiovascular research at the Minneapolis Heart Institute Foundation, says it's difficult to extrapolate the results of this study directly to the situation in the United States, "but it is very helpful in supporting the idea that screening can make a difference." Despite the lack of studies showing the efficacy of screening, Glover and Maron contend that the screening inadequacies they identified hamper the ability of the process to achieve its full potential. "It is reasonable to expect that improvement and optimization of the preparticipation screening process will permit more frequent detection of cardiovascular lesions associated with sudden death and morbidity in young competitive athletes," their article states. Some physicians, however, hesitate to embrace national screening using the AHA guidelines until efficacy and cost-effectiveness studies show a benefit. William L. Risser, MD, clinical professor of pediatrics at the University of Texas Houston Health Science Center, says that certain elements of preparticipation screening—parental input on the family history, for example—should not be mandated if doing so would obstruct sports participation among athletes of low socioeconomic status, "especially when the risk involved is small and the new intervention is unproven." Raising the Legal StakesMaron says that the risk of legal liability may push state and national organizations to address the report's conclusions. "This paper can be and would be used to demonstrate that states and school districts have not measured up to the standard of care," Maron says. "The paper clearly draws a line in the sand—theoretically, the landscape has changed." David L. Herbert, JD, a medicolegal expert and partner at Herbert & Benson in Canton, Ohio, says he agrees that Glover and Maron's article could have "profound potential medicolegal significance" and might be used in unnecessary- death claims and litigation. "Since these expressed opinions come from very respected professionals, they might be very easily adapted to legal claims and suits," says Herbert, an editorial board member of The Physician and Sportsmedicine. Herbert notes that the JAMA article isn't the first to call for a national cardiac preparticipation exam standard. In 1996, the AHA's statement on cardiovascular screening (2) recommended a national standard for preparticipation medical evaluations, along with better training for healthcare workers who give the exams. (See "AHA Panel Outlines Sudden Death Screening Standards," October 1996, page 27.) Steps Toward a StandardGlover says the most logical group to spur the adoption of a national standard is the National Federation of State High School Associations (NFHS), based in Kansas City, Missouri. Though the NFHS has no regulatory power over the state associations, Glover says, its role is crucial because all 50 states and the District of Columbia belong to and communicate regularly with the organization. The NFHS distributed the original joint PPE monograph sponsored by five medical societies (4) to its 51 members in 1992, and did the same with the revised version in 1996 (5), says Glover, who collaborates with the NFHS as a liaison from the Missouri State High School Activities Association and a liaison from the American Medical Society for Sports Medicine (AMSSM). The time may be ripe for the NFHS to provide a stronger push for a national preparticipation standard; two years ago it established a sports medicine advisory committee, which includes two representatives from the AMSSM, Glover says. "Documenting the inadequacy of the forms that most states use is a stimulus," he says, and the sports medicine committee "provides a mechanism for getting something done." Jerry L. Diehl, NFHS assistant director, says enforcement of a national PPE standard, if one were adopted, might be difficult because federation membership is voluntary, and the national organization does not have a role in state association governance. Currently, the federation constitution and bylaws briefly address the medical, statutory, insurance, and liability rationales for the PPE, but do not designate what standard states should use for the exams, he says. "That's left to the discretion of the state associations," he says. Diehl says the NFHS's sports medicine committee will discuss the idea of a national PPE standard when it meets in mid-October. The committee may recommend bylaw changes to the NFHS board of directors, which meets in late October. References
Lisa Schnirring
Leptospirosis Cases Linked to TriathlonsIn an effort to control a leptospirosis outbreak, the Centers for Disease Control and Prevention (CDC) in Atlanta and state health departments are contacting 1,850 athletes from 44 states who participated in two triathlons in the Midwest this summer. The events were held in Springfield, Illinois, June 21, and Madison, Wisconsin, July 5 (1). Leptospirosis, a spirochetal zoonosis, causes a wide array of symptoms, including fever, headache, chills, myalgia, and sometimes a rash (2). It is spread to humans by contact with water contaminated with the urine of infected animals (1). Since 1970, most cases have occurred in home and recreational settings (ie, freshwater swimming, canoeing and kayaking, trail biking, hunting). The incubation is typically 7 to 12 days but can range from 2 to 20 days. The diagnosis is based on a fourfold or greater rise in antibody titers in patients who are in the acute or convalescent stages. Treatment involves supportive measures along with penicillin, amoxicillin, ampicillin, doxycycline, or tetracycline to reduce the severity and duration of symptoms. David Wang, MD, director of the general medicine and sports medicine clinics at Boynton Health Service and team physician at the University of Minnesota in Minneapolis, recently treated one of the affected athletes. The patient, a 24-year-old man, had participated in the Springfield, Illinois, triathlon. Wang says the athlete, without mentioning his triathlon participation, initially presented 24 days after the event with classic viremia symptoms—fever, headache, and myalgia. He was advised to rest at home and take acetaminophen, which seemed to relieve his symptoms, says Wang, who is an editorial board member of The Physician and Sportsmedicine. The patient returned after the Minnesota Department of Health notified him about the leptospirosis outbreak, Wang reports. Wang ordered lab tests; liver enzymes were elevated and the albumin was decreased. The patient's serum specimen was positive for Leptospira grippotyphosa. Wang prescribed doxycycline 100 mg, twice a day for 10 days. The patient redeveloped a bad headache, unaccompanied by meningitis symptoms, but then slowly improved, Wang says. References
News From the AOSSM Annual MeetingThe 24th annual meeting of the American Orthopaedic Society for Sports Medicine (AOSSM) was held in July in Vancouver, British Columbia. Here are some highlights of the meeting, according to press releases and reports from the AOSSM.
RETURN TO SEPTEMBER 1998 TABLE OF CONTENTS
Copyright (C) 1998. The McGraw-Hill Companies. All Rights Reserved Privacy Policy. Privacy Notice. |